Long-term results of a hydroxyapatite-coated femoral component in total hip replacement : A 15- To 21-Year Follow-Up Study
S. S. Rajaratnam, C. Jack, A. Tavakkolizadeh, M. D. George, R. J. Fletcher, M. Hankins, J. A. N. Shepperd
Category: Furlong Clinical Results
Results from The Conquest Hospital, St Leonards-on-Sea
Between 1986 and 1991 we implanted 331 consecutive Furlong hydroxyapatite-coated femoral components of a total hip replacement in 291 patients. A cemented acetabular prosthesis was used in 217 hips and a hydroxyapatite-coated component in 114. We describe the long-term clinical and radiological survival of the femoral component at a mean follow-up of 17.5 years (15 to 21). Only two patients (0.68%) were lost to follow-up. With revision of the femoral component for any reason as the endpoint, the survival at a mean of 17 years was 97.4% (95% confidence interval 94.1 to 99.5), and with revision for aseptic loosening as the endpoint it was 100%. The survival at a maximum of 21 years with revision of the femoral component for any reason as the endpoint was 97.4% (95% confidence interval 81.0 or 99.5). These results compare favourably with the best long-term results of cemented or uncemented femoral components used in total hip replacement.
Journal of Bone and Joint Surgery, January 2008
J Bone Joint Surg [Br] 2008; 90-B : 27-30.